NCT01490294 - Myocardial Perfusion MRI | Biotech Hunter

Enrollment

232

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Myocardial Perfusion ImagingMagnetic Resonance Imaging

Interventions

DRUG

Gadobutrol (Gadavist,Gadovist, BAY86-4875)

0.01 mmol/kg BW (0.01 mL/kg) for stress MRI and 0.01 mmol/kg BW (0.01 mL/kg) for rest MRI (total dose 0.02 mmol/kg)

DRUG

Gadobutrol (Gadavist,Gadovist, BAY86-4875)

0.025 mmol/kg BW (0.025 mL/kg) for stress MRI and 0.025 mmol/kg BW (0.025 mL/kg) for rest MRI (total dose 0.05 mmol/kg)

DRUG

Gadobutrol (Gadavist,Gadovist, BAY86-4875)

0.05 mmol/kg BW (0.05 mL/kg) for stress MRI and 0.05 mmol/kg BW (0.05 mL/kg) for rest MRI (total dose 0.1 mmol/kg)

DRUG

Gadobutrol (Gadavist,Gadovist, BAY86-4875)

0.1 mmol/kg BW (0.1 mL/kg) for stress MRI and 0.1 mmol/kg BW (0.1 mL/kg) for rest MRI (total dose 0.2 mmol/kg)

Trial Locations (14)

3100

Pölten

4031

Basel

10115

Berlin

31202

Krakow

32545

Bad Oeynhausen

45138

Essen

53127

Bonn

60389

Frankfurt am Main

72076

Tübingen

79106

Freiburg im Breisgau

81377

München

81675

München

89075

Ulm

CH-6900

Lugano